Owner Amgen Inc.

Inventors Boyle, William J.

Agent Shelston IP

Pub. Number AU-B-2005201799

Parent 779461

Filing date 27 April 2005

Wipo publication date 26 May 2005

Acceptance publication date 12 June 2008

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

A61K 31/70 (2006.01) - Carbohydrates

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

G01N 33/577 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving monoclonal antibodies

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids